Clazakizumab (Anti-IL-6 Monoclonal) as an Agent to Reduce Donor Specific Hla Antibodies (DSA) and Improve Outcomes in Patients with Chronic & Active Antibody-Mediated Rejection Post-Kidney Transplantation (NCT03380377)

被引：0
|
作者：
Jordan, S. C. [1 ]
Ammerman, N. [1 ]
Toyoda, M. [1 ]
Ge, S. [1 ]
Huang, E. [1 ]
Peng, A. [1 ]
Sethi, S. [1 ]
Najjar, R. [1 ]
Ortiz, E. [1 ]
Chu, M. [1 ]
De Guzman, A. [1 ]
Kim, I. [1 ]
Lim, K. [1 ]
Choi, J. [1 ]
Vo, A. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2020年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B-63
引用
收藏
页码：848 / 849
页数：2
相关论文
共 25 条
  • [1] CLAZAKIZUMAB (ANTI-IL-6 MONOCLONAL) TREATMENT OF PATIENTS WITH CHRONIC & ACTIVE ANTIBODY-MEDIATED REJECTION POST-KIDNEY TRANSPLANTATION (NCT03380377)
    Jordan, Stanley
    Ammerman, Noriko
    Toyoda, Mieko
    Ge, Shili
    Huang, Edmund
    Peng, Alice
    Sethi, Supreet
    Najjar, Reiad
    Ortiz, Edwin
    Chu, Maggie
    De Guzman, Abner
    Kim, Irene
    Lim, Kathlyn
    Choi, Jua
    Vo, Ashley A.
    TRANSPLANTATION, 2020, 104 (09) : S67 - S68
  • [2] Clazakizumab (Anti-IL6 Monoclonal) to Reduce Donor Specific HLA Antibodies (DSA) and Improve Outcomes in Post- Kidney Transplant Patients with Chronic Active Antibody Mediated Rejection (NCT03380377)
    Jordan, S. C.
    Ammerman, N.
    Huang, E.
    Peng, A.
    Najjar, R.
    Kim, I.
    Hernando, K.
    Bui, V.
    Choi, J.
    Lim, K.
    Badash, N.
    Gillespie, M.
    Vo, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S489 - S489
  • [3] Clazakizumab as an Agent to Reduce Donor Specific HLA Antibodies and Improve Outcomes in Patients with Chronic & Active Antibody-Mediated Rejection Post-Kidney Transplantation.
    Jordan, S. C.
    Ammerman, N.
    Toyoda, M.
    Huang, E.
    Nast, C. C.
    Peng, A.
    Sethi, S.
    Najjar, R.
    Kim, I.
    Lim, K.
    Choi, J.
    Vo, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 452 - 452
  • [4] EVALUATION OF CLAZAKIZUMAB (ANTI-IL-6) FOR TREATMENT OF KIDNEY TRANSPLANT RECIPIENTS WITH CHRONIC & ACTIVE ANTIBODY MEDIATED REJECTION
    Jordan, Stanley
    Ammerman, Noriko
    Toyoda, Mieko
    Huang, Edmund
    Nast, Cynthia
    Peng, Alice
    Sethi, Supreet
    Najjar, Reiad
    Kim, Irene
    Lim, Kathlyn
    Choi, Jua
    Vo, Ashley
    TRANSPLANT INTERNATIONAL, 2019, 32 : 400 - 401
  • [5] Clazakizumab (CLZ, Anti-IL-6 Monoclonal Antibody) Treatment of Patients (Pts) with Chronic Antibody-Mediated Rejection (cABMR) Reduces Total Immunoglobulin (Ig) and Anti-HLA IgG Antibody Levels.
    Shin, B.
    Ammerman, N. F.
    Vo, A. A.
    Zhang, X.
    Jordan, S. C.
    Toyoda, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 667 - 667
  • [6] Chronic Active Antibody-Mediated Rejection With Donor-Specific Anti-HLA-DP Antibodies Following Living Donor Kidney Transplantation: A Case Report
    Fukuoka, Kengo
    Tokodai, Kazuaki
    Miyagi, Shigehito
    Nakanishi, Wataru
    Nishimura, Ryuichi
    Fujio, Atsushi
    Watanabe, Hirofumi
    Taniuchi, Shinji
    Naitoh, Takeshi
    Ishida, Takanori
    Unno, Michiaki
    Kamei, Takashi
    TRANSPLANTATION PROCEEDINGS, 2020, 52 (06) : 1937 - 1939
  • [7] Graft Outcomes of Antibody Mediated Rejection without Donor Specific Anti - HLA Antibodies After Kidney Transplantation
    Ko, H.
    Min, S.
    Han, A.
    Ahn, S.
    Chung, C. T.
    Kim, H.
    Choi, K.
    Min, S.
    Kang, H.
    Ha, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 731 - 731
  • [8] Monitoring Inflammatory Cytokine Levels in Kidney Transplant Patients (KTx Pts) with Chronic Antibody Mediated Rejection (cABMR) Treated with Clazakizumab (CLZ, Humanized Anti-IL-6 Monoclonal Antibody).
    Ge, S.
    Petrosyan, A.
    Chu, M.
    Ammerman, N.
    Vo, A.
    Jordan, S. C.
    Zhang, X.
    Toyoda, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 661 - 661
  • [9] Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation
    Malheiro, Jorge
    Tafulo, Sandra
    Dias, Leonidio
    Martins, La Salete
    Fonseca, Isabel
    Beirao, Idalina
    Castro-Henriques, Antonio
    Cabrita, Antonio
    TRANSPLANT IMMUNOLOGY, 2015, 32 (02) : 66 - 71
  • [10] Evaluation of Clazakizumab (Anti-Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts
    Jordan, Stanley C.
    Ammerman, Noriko
    Choi, Jua
    Huang, Edmund
    Najjar, Reiad
    Peng, Alice
    Sethi, Supreet
    Sandhu, Rana
    Atienza, Janet
    Toyoda, Mieko
    Ge, Shili
    Lim, Kathlyn
    Gillespie, Matthew
    Zhang, Xiaohai
    Haas, Mark
    Vo, Ashley
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (04): : 720 - 731
123